RealVNC mid banner careers
Advertisement – Charles Stanley mid banner
Advertisement: Mogrify mid banner
Advertisement: EY Mid banner
Advertisement: Howard Group mid banner
ARM Innovation Hub
Advertisement: EBCam mid banner
Advertisement: RSM
Mid banner advertisement: BDO
Advertisement: Hewitsons mid banner
Advertisement: Kao Data Centre mid banner
Advertisement: Cambridge Network mid banner
Advertisement: Simpsons Creative
Barr Ellison Solicitors – commercial property
Advertisement mid banner S-Tech 1
25 November, 2020 - 16:57 By Tony Quested

Bicycle CLIPS cost €4m+

Bicycle Therapeutics in Cambridge

Bicycle Therapeutics plc in Cambridge has settled IP disputes worldwide with Dutch company Pepscan Systems B.V. regarding Bicycle’s use of Pepscan’s CLIPS peptide technology.

Bicycle has been granted a licence to use CLIPS in the development of its product candidates BT1718 and THR-149. 

It will pay €3 million upfront, €1 million on the first anniversary of the date of settlement and make potential additional payments to Pepscan based on achievement of specified clinical, regulatory and commercial milestones.

Nasdaq-quoted Bicycle Therapeutics is pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology.

Newsletter Subscription

Stay informed of the latest news and features